首页 | 本学科首页   官方微博 | 高级检索  
检索        

慢性阻塞性肺疾病患者C反应蛋白水平变化及其临床意义
引用本文:郑法德.慢性阻塞性肺疾病患者C反应蛋白水平变化及其临床意义[J].蚌埠医学院学报,2009,34(6):512-514.
作者姓名:郑法德
作者单位:安徽省阜阳市人民医院呼吸科, 236000
摘    要:目的:探讨C反应蛋白(C reactive protein,CRP)在慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)不同时期的水平变化及其临床应用价值。方法:检测64例COPD急性加重期患者(AECOPD)与62例缓解期患者的血清CRP水平、白细胞计数(WBC)及中性粒细胞比值(NE%)。结果:AECOPD患者CRP为(53.8±15.3)mg/L,缓解期为(6.4±5.8)mg/L,差异有统计学意义(P<0.01);AECOPD患者CRP阳性率为96.88%,显著高于WBC和NE%的阳性率(P<0.01和P<0.05)。结论:COPD患者CRP值在急性加重期明显升高,血清CRP水平是AECOPD诊断的优选指标。

关 键 词:肺疾病  阻塞性    C反应蛋白
收稿时间:2008-09-26

Changes of the level of C reactive protein in patients with chronic obstructive pulmonary disease and its clinical significance
ZHENG,Fa-de.Changes of the level of C reactive protein in patients with chronic obstructive pulmonary disease and its clinical significance[J].Journal of Bengbu Medical College,2009,34(6):512-514.
Authors:ZHENG  Fa-de
Institution:Department of Respiractory Diseases, Fuyang People's Hospital, Fuyang Anhui 236000, China
Abstract:Objective:To observe C-reactive protein (CRP) level variation in patients with chronic obstructive pulmonary disease (COPD) and to investigate its clinical significance. Methods:The serum CRP level of 64 patients with COPD at acute exacerbation (AECOPD) and 62 patients at stable stage was measured, and the white blood cells (WBC) and percentage of neutrophils (NE%) were also collected. Results : The serum CRP level of AECOPD patients ( 53.8 ± 15.3 ) mg/L was significantly higher than that of the patients at the stable stage ( 6.4 ± 5.8 ) mg/L ( P 〈 0.01 ) ; the positive rate of the serum CRP of AECOPD patients was significantly higher (96.88%) than that of WBC ( P 〈 0.01 ) and NE% ( P 〈 0.05 ). Conclusions: The serum CRP level of COPD patients increases significantly at the acute exacerbation stage and it is a preferential index in diagnosis of AECOPD.
Keywords:lung disease  obstructive  C-reactive protein
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《蚌埠医学院学报》浏览原始摘要信息
点击此处可从《蚌埠医学院学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号